These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 34404063)

  • 1. [Clinical Guidelines for Cancer Chemotherapy under COVID-19 in the World].
    Katsumata N
    Gan To Kagaku Ryoho; 2021 Aug; 48(8):992-995. PubMed ID: 34404063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.
    Madhusoodhan PP; Pierro J; Musante J; Kothari P; Gampel B; Appel B; Levy A; Tal A; Hogan L; Sharma A; Feinberg S; Kahn A; Pinchinat A; Bhatla T; Glasser CL; Satwani P; Raetz EA; Onel K; Carroll WL
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28843. PubMed ID: 33338306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ray JG; Schull MJ; Vermeulen MJ; Park AL
    Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
    van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
    BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid cancer and COVID-19: experience at one single thyroid disease referral center.
    Prete A; Falcone M; Bottici V; Giani C; Tiseo G; Agate L; Matrone A; Cappagli V; Valerio L; Lorusso L; Minaldi E; Molinaro E; Elisei R
    Endocrine; 2021 May; 72(2):332-339. PubMed ID: 33638758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
    Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
    Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and oncological disease.
    Šálek T; Slopovský J; Pörsök Š; Pazderová N; Mináriková Z; Zomborská E; Špánik B
    Klin Onkol; 2021; 34(3):211-219. PubMed ID: 34362259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
    Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
    Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
    Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
    Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
    Song SH; Chen TL; Deng LP; Zhang YX; Mo PZ; Gao SC; Hu WJ; Xiong Y; Ma ZY
    Infect Dis Poverty; 2020 Jul; 9(1):82. PubMed ID: 32616030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Illness Severity Among Pregnant Women With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection-Surveillance for Emerging Threats to Mothers and Babies Network, 22 State, Local, and Territorial Health Departments, 29 March 2020-5 March 2021.
    Galang RR; Newton SM; Woodworth KR; Griffin I; Oduyebo T; Sancken CL; Olsen EO; Aveni K; Wingate H; Shephard H; Fussman C; Alaali ZS; Silcox K; Siebman S; Halai UA; Lopez CD; Lush M; Sokale A; Barton J; Chaudhary I; Patrick PH; Schlosser L; Reynolds B; Gaarenstroom N; Chicchelly S; Read JS; de Wilde L; Mbotha D; Azziz-Baumgartner E; Hall AJ; Tong VT; Ellington S; Gilboa SM;
    Clin Infect Dis; 2021 Jul; 73(Suppl 1):S17-S23. PubMed ID: 34021332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infections in cancer outpatients-Most infected patients are asymptomatic carriers without impact on chemotherapy.
    Hempel L; Piehler A; Pfaffl MW; Molnar J; Kirchner B; Robert S; Veloso J; Gandorfer B; Trepotec Z; Mederle S; Keim S; Milani V; Ebner F; Schweneker K; Fleischmann B; Kleespies A; Scheiber J; Hempel D; Zehn D
    Cancer Med; 2020 Nov; 9(21):8020-8028. PubMed ID: 33022856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?
    Bi J; Ma H; Zhang D; Huang J; Yang D; Wang Y; Verma V; Zhang T; Hu D; Mei Q; Han G; Li J
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32883679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey.
    Gheorghe AS; Negru ŞM; Nițipir C; Mazilu L; Marinca M; Gafton B; Ciuleanu TE; Schenker M; Dragomir RD; Gheorghe AD; Stovicek PO; Bandi-Vasilica M; Boț AC; Mihăilă RI; Zob DL; Kajanto AL; Stănculeanu DL
    ESMO Open; 2021 Feb; 6(1):100027. PubMed ID: 33399089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland.
    Matuschek C; Fischer JC; Combs SE; Fietkau R; Corradini S; Zänker K; Bölke E; Djiepmo-Njanang FJ; Tamaskovics B; Fischer JE; Stuschke M; Pöttgen C; Förster R; Zwahlen DR; Papachristofilou A; Ganswindt U; Pelka R; Schneider EM; Feldt T; Jensen BEO; Häussinger D; Knoefel WT; Kindgen-Milles D; Pedoto A; Grebe O; van Griensven M; Budach W; Haussmann J
    Strahlenther Onkol; 2020 Dec; 196(12):1068-1079. PubMed ID: 32914236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
    Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of the COVID-19 Outbreak on the management of patients with gynecological cancers].
    Lamblin G; Golfier F; Peron J; Moret S; Chene G; Nohuz E; Lebon M; Dubernard G; Cortet M
    Gynecol Obstet Fertil Senol; 2020 Nov; 48(11):777-783. PubMed ID: 33010487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.
    Bilich T; Roerden M; Maringer Y; Nelde A; Heitmann JS; Dubbelaar ML; Peter A; Hörber S; Bauer J; Rieth J; Wacker M; Berner F; Flatz L; Held S; Brossart P; Märklin M; Wagner P; Erne E; Klein R; Rammensee HG; Salih HR; Walz JS
    Cancer Discov; 2021 Aug; 11(8):1982-1995. PubMed ID: 34011563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful and Safe Reinstitution of Chemotherapy for Pancreatic Cancer after COVID-19.
    Nagai K; Kitamura K; Hirai Y; Nutahara D; Nakamura H; Taira J; Matsue Y; Abe M; Kikuchi M; Itoi T
    Intern Med; 2021 Jan; 60(2):231-234. PubMed ID: 33229812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?
    Fedele P; Sanna V; Fancellu A; Marino A; Calvani N; Cinieri S
    Crit Rev Oncol Hematol; 2021 Jan; 157():103148. PubMed ID: 33254036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.